Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Leo

Showing results (241-250 of 259) with videos related to

Pageof 26
Sort By:
The Journal of Organic Chemistry|February 19, 2008
Suzuki-Miyaura approach to JNJ-26076713, an orally active tetrahydroquinoline-containing alphaVbeta3/alphaVbeta5 integrin antagonist. enantioselective synthesis and stereochemical studiesWilliam A Kinney, Christopher A Teleha, Andrew S Thompson, et al.
Blood|October 9, 2013
Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defectsJacqueline Stockley, Neil V Morgan, Danai Bem, et al.
Blood|January 11, 2014
Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assayMarie Lordkipanidzé, Gillian C Lowe, Nicholas S Kirkby, et al.
Genetics in Medicine Open|December 13, 2024
Feasibility of an electronic patient-facing cancer family history tool in medically underserved populationsHeather Spencer Feigelson, Kathleen F Mittendorf, Sonia Okuyama, et al.
Minerva Anestesiologica|January 12, 2021
The management of pediatric severe traumatic brain injury: Italian GuidelinesLeonardo Bussolin, Martina Falconi, Maria C Leo, et al.
Urology|November 25, 2018
Factors That Influence Selectionof Urinary Diversion Among Bladder Cancer Patients in 3 Community-based Integrated Health Care SystemsMarilyn L Kwan, Michael C Leo, Kim N Danforth, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2004
1,2,3,4-Tetrahydroquinoline-containing alphaVbeta3 integrin antagonists with enhanced oral bioavailabilityShyamali Ghosh, Rosemary J Santulli, William A Kinney, et al.
Cancer Medicine|August 30, 2023
Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort studyBoya Guo, Sarah Knerr, Tia L Kauffman, et al.
Familial Cancer|March 23, 2021
Adaptation and early implementation of the PREdiction model for gene mutations (PREMM<sub>5</sub>™) for lynch syndrome risk assessment in a diverse populationKathleen F Mittendorf, Chinedu Ukaegbu, Marian J Gilmore, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 6, 2022
ORCA, a values-based decision aid for selecting additional findings from genomic sequencing in adults: Efficacy results from a randomized trialElizabeth G Liles, Michael C Leo, Amanda S Freed, et al.
Pageof 26

Showing results (241-250 of 259) with videos related to

Sort By:
Pageof 26
The Journal of Organic Chemistry|February 19, 2008
Suzuki-Miyaura approach to JNJ-26076713, an orally active tetrahydroquinoline-containing alphaVbeta3/alphaVbeta5 integrin antagonist. enantioselective synthesis and stereochemical studiesWilliam A Kinney, Christopher A Teleha, Andrew S Thompson, et al.
Blood|October 9, 2013
Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defectsJacqueline Stockley, Neil V Morgan, Danai Bem, et al.
Blood|January 11, 2014
Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assayMarie Lordkipanidzé, Gillian C Lowe, Nicholas S Kirkby, et al.
Genetics in Medicine Open|December 13, 2024
Feasibility of an electronic patient-facing cancer family history tool in medically underserved populationsHeather Spencer Feigelson, Kathleen F Mittendorf, Sonia Okuyama, et al.
Minerva Anestesiologica|January 12, 2021
The management of pediatric severe traumatic brain injury: Italian GuidelinesLeonardo Bussolin, Martina Falconi, Maria C Leo, et al.
Urology|November 25, 2018
Factors That Influence Selectionof Urinary Diversion Among Bladder Cancer Patients in 3 Community-based Integrated Health Care SystemsMarilyn L Kwan, Michael C Leo, Kim N Danforth, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2004
1,2,3,4-Tetrahydroquinoline-containing alphaVbeta3 integrin antagonists with enhanced oral bioavailabilityShyamali Ghosh, Rosemary J Santulli, William A Kinney, et al.
Cancer Medicine|August 30, 2023
Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort studyBoya Guo, Sarah Knerr, Tia L Kauffman, et al.
Familial Cancer|March 23, 2021
Adaptation and early implementation of the PREdiction model for gene mutations (PREMM<sub>5</sub>™) for lynch syndrome risk assessment in a diverse populationKathleen F Mittendorf, Chinedu Ukaegbu, Marian J Gilmore, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 6, 2022
ORCA, a values-based decision aid for selecting additional findings from genomic sequencing in adults: Efficacy results from a randomized trialElizabeth G Liles, Michael C Leo, Amanda S Freed, et al.
Pageof 26